A study of the Effects of Inhaled Fliticasone Furotate/GW642444 versus Placebo on HPA Axis of Adolescent and Adult Asthmatics

Update Il y a 4 ans
Reference: EUCTR2009-017669-44

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to assess the effect of six weeks’ treatment with two once-daily strengths of Fluticasone Fuorate /GW642444 Inhalation Powder on the hypothalamic-pituitary-adrenal (HPA) axis system compared with placebo. A 7-day course of oral prednisolone is included as an active control to ensure the assay is sufficiently sensitive to detect a drug effect.


Inclusion criteria

  • Adolescent (12-17 years) and Adult Asthmathics